Navigation Links
Mass spec makes the clinical grade
Date:9/3/2012

RICHLAND, Wash. -- Combining two well-established analytic techniques and adding a twist identifies proteins from blood with as much accuracy and sensitivity as the antibody-based tests used clinically, researchers report this week in Proceedings of the National Academy of Sciences Early Edition online. The technique should be able to speed up development of diagnostic tests and treatments based on proteins specific to certain diseases.

The team of scientists at the Department of Energy's Pacific Northwest National Laboratory found that their technique, called PRISM, performed as accurately as standard clinical tests known as ELISAs in a head-to-head comparison using blood samples from cancer patients. The tests measure biomarkers, proteins whose presence identifies a disease or condition.

"Clinical tests have almost always used antibodies to measure biomarkers, because antibodies can provide good sensitivity," said PNNL bioanalytical chemist Wei-Jun Qian, lead author on the study. "But it often takes a year and a half to develop antibodies as tools. Antibody development is one of the bottlenecks for new biomarker studies in disease and systems biology research."

Qian, Tujin Shi, Tom Fillmore and their PNNL colleagues worked out the highly sensitive PRISM using resources at DOE's EMSL, the Environmental Molecular Sciences Laboratory on PNNL's campus. The result is a simple and elegant integration of existing technologies that solves a long-standing problem.

The Competition

Researchers have long wanted to use mass spectrometry to identify proteins of interest within biological samples. Proteins are easy to detect with mass spec, but it lacks the sensitivity to detect rare proteins that exist in very low concentrations. Scientists use antibodies to detect those rare proteins, which work like a magnet pulling a nail out of a haystack.

Antibodies are immune system molecules that recognize proteins
'/>"/>

Contact: Mary Beckman
mary.beckman@pnnl.gov
509-375-3688
DOE/Pacific Northwest National Laboratory
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. As Released on 30 December, 2011: Novogen Modifies ADR Program and Makes Further Investment Into Marshall Edwards
2. The Lancet Makes Research More Accessible for Healthcare Professionals With New App for iPad
3. GeNO LLC Makes Significant Additions to Management Team to Increase Capability and Talent
4. Oracle chairman Jeff Henley makes $50 million gift to UC Santa Barbara
5. Foundation Venture Capital Group Makes Eighth Start-Up Investment
6. Infectious Disease Prevalence and New Strains Appearing Each Year Makes a Watertight Case for Clinical Laboratory Testing, Finds Frost & Sullivan
7. Chemical makes blind mice see; compound holds promise for treating humans
8. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
9. Positive Clinical Study Results for BSPs HyperQ Technology
10. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
11. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Earlier this year in a June 24 international ... Adult Stem Cell Technology Center, LLC ( ASCTC ) ... unique property of adult tissue stem cells. His ... the Past, Important for the Future,” embodied the essence ... the address at the 4th World Congress on Cell ...
(Date:12/24/2014)... The report provides basic ... definition, classification, application and industry overview. This ... and product cost structure. Production is separated ... also covers upstream raw materials, equipment, downstream ... and proposals. In the end, the export ...
(Date:12/24/2014)... , Dec. 23, 2014 China Biologic ... "Company"), a leading fully integrated plasma-based biopharmaceutical company ... that its majority-owned subsidiary, Shandong Taibang Biological Products ... certification from the China Food and Drug Administration ... facility. As previously disclosed in the Company,s public ...
(Date:12/24/2014)... , Dec. 23, 2014  Rock Creek Pharmaceuticals, ... it has filed a Clinical Trial Application (CTA) with ... products Regulatory Agency (MHRA) seeking regulatory approval to initiate ... molecule, Anatabine Citrate. Contingent on the Company ... a Phase I trial to assess the safety, tolerability ...
Breaking Biology Technology:Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
... Although Madison has made a deal with Georgia-based ... deployment will not be an overnight event. Certain areas will ... around Capitol Square expected to be approved by the City ... the city of Madison has taken an active role in ...
... vice president Kevin Conroy is stepping into the shoes of ... and previously held other executive roles at the company, has ... a specific purpose," Puisis said in a statement. "With a ... place, that purpose has been completed." , ,Third Wave is ...
... has tripled Third Wave Technologies ' compensation in ... $15.9 million plus legal fees. Stratagene is proceeding with ... after the judge found that Stratagene willfully infringed on ... Third Wave $5.3 million. , ,Third Wave uses the ...
Cached Biology Technology:Madison wireless deal goes forward with Cellnet 2
(Date:11/21/2014)... According to a new market research report ... Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), End ... - Global Forecasts to 2020", published by MarketsandMarkets, The ... $25 Billion in 2014 and is expected to reach ... 8.69%. Browse 116 market data Tables and ...
(Date:11/21/2014)... 20, 2014 C-Labs LLC, a leading provider ... Things (IoT), today announced the appointment of John ... Previously a strategic advisor to the firm, Mr. Traynor ... Traynor is based out of the C-Labs office in ... Chris Muench , Chief Executive Officer. ...
(Date:11/18/2014)... BOSTON , Nov. 17, 2014   ... HealthCare and EMC collaborate to develop The Partners ... , The Partners Data Lake will allow ... to improve diagnostics, treatment and the lives of ... support research and clinical activities across the Partners ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
... in immune cells may be a reliable marker for ... appearing in the July issue of Molecular and ... and complex psychiatric illness that affects about 1% of ... and the assessment of ambiguous symptoms, which frequently leads ...
... JULY 7, 2008 -- The Soil Science Society of ... Sherrod Brown and his colleagues in the Senate who ... "essential" natural resource, placing soil on par with water ... joined by co-sponsoring Senators Kent Conrad (D-ND), Charles Grassley ...
... The effective treatment of many forms of cancer continues ... fail to respond to standard forms of chemotherapy or ... Centre for Infection Research (HZI) in Braunschweig, the Hannover ... now discovered a chemical mechanism with which a natural ...
Cached Biology News:Senate resolution shines spotlight on the importance of soils 2Argyrin: Natural substance raises hope for new cancer therapies 2
GLP-1 (HYB 147-12)...
... Custom Synthesis Service provides you ... to knockdown any gene. We ... base pairs with terminal dT ... other lengths of your choice. ...
EDG-1 Western blot control Source: Cell Lysate Application: Western Blotting Control...
Kit containing positive control DNA all parts of the HIV-1 genome, HIV-1 negative control DNA, Primers SK38, SK39, SK19...
Biology Products: